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ABSTRACT
The three structural domains of transcription elonga-
tion factor TFIIS are conserved from yeast to human.
Although the N-terminal domain is not needed for
transcriptional activity, a similar sequence has been
identified previously in other transcription factors.
We found this conserved sequence, the LW motif,
in another three human proteins that are predomi-
nantly nuclear localized. We investigated two exam-
ples to determine whether the LW motif is actually a
dedicated nuclear targeting signal. However, in one
of the newly identified proteins, hIWS1 (human Iws1),
a region containing classic nuclear localization
signals(NLS)ratherthan theLWmotifwasnecessary
and sufficient for nuclear targeting in HeLa cells. In
contrast, human TFIIS does not possess an NLS and
only constructs containing the LW motif were effi-
ciently targeted to nuclei. Moreover, mutations in
the motif could cause cytoplasmic accumulation of
TFIIS and enabled a structure/function assay for the
domain based on the efficiency of nuclear targeting.
Finally, GST pull-down assays showed that the LW
motif is part of a protein-binding domain. We suggest
that the targeting role the LW motif plays in TFIIS
arises from its more general function as a protein
interaction domain, enabling TFIIS to bind a carrier
protein(s) that accomplishes nuclear import.
INTRODUCTION
It has emerged recently that many of the stages of gene
expression that occur in the nucleus are mechanistically
and/or kinetically coupled [reviewed by (1–3)]. It is also
becoming apparent that one important principle underlying
the integration of nuclear events is the organization of the
nucleus into distinctive structural and functional compart-
ments, among which the best understood are nucleoli, speckles
and Cajal bodies (4,5). Taking the latter as an example, this
nuclear organelle is thought, amongst other things, to be a site
for interaction, modiﬁcation and assembly of macromolecular
complexes involved both in transcription by RNA polymerase
(pol) II and the processing of pre-mRNAs. The activities of
Cajal bodies may even extend to the generation of integrated,
multifunctional ‘mRNA machines’ or transcriptosomes (6,7).
Another principle underlying the co-ordination of gene
expression appears to be the involvement of multifunctional
components in different processes or distinctive stages of a
process [reviewed by (8–10)]. An example is the transcription
factor TFIIS. This protein was ﬁrst identiﬁed as a transcription
elongation factor via biochemical assays that showed it
increased the overall transcription rate of pol II by reactivating
elongation complexes whose progress had been blocked by a
variety of impediments [reviewed by (11,12)]. TFIIS is
thought to accomplish this by activating an intrinsic pol II
transcript cleavage activity and then stimulating the arrested
elongation complex to re-initiate chain elongation, enabling
repeated attempts eventually to clear the transcription block.
Recent crystallographic studies of the yeast TFIIS-pol II com-
plex (13,14) have revealed the likely mechanism of transcript
cleavage. TFIIS binds the surface of pol II and inserts its
C-terminal region through the pol II pore such that it contacts
the enzyme’s internal active site. Co-ordination of a metal ion
by invariant acidic residues in this region of TFIIS is thought
to enable hydrolytic RNA cleavage by the pol II active site
(13). In agreement with the crystal structure it is known that
the C-terminal two-thirds of TFIIS is sufﬁcient for in vitro
transcriptional stimulation and this region is also all that is
needed for the activities of nascent RNA cleavage, arrest read-
through and pol II binding that have been deﬁned biochemi-
cally for intact TFIIS. Conversely, a function has not yet been
assigned to the N-terminal 130 amino acids or so of TFIIS that
*To whom correspondence should be addressed. Tel: +44 115 823 0390; Fax: +44 115 823 0313; Email: garry.morgan@nottingham.ac.uk
Present address:
Abigail J. Smith, Department of Biochemistry, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, UK
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
Nucleic Acids Research, 2006, Vol. 34, No. 8 2219–2229
doi:10.1093/nar/gkl239are not included in the crystal structure. However, one of the
few known properties of this region is that it interacts directly
with an initiation-competent form of pol II holoenzyme,
suggesting TFIIS may be a multifunctional protein that is
alsoinvolved in controlling an earlier stage of the transcription
cycle (15).
The N-terminal region of TFIIS may also reveal another
potential mechanism important in co-ordinating nuclear acti-
vities, namely the presence of common structural domains
among nuclear proteins with distinctive functions. A sequence
motif in the N-terminal region that is well conserved between
thedifferentisoformsofTFIISencodedbyvertebrategenomes
and between vertebrate and yeast TFIIS (16,17), has also been
identiﬁed in two other transcriptional proteins. These are
MED26 (also known as CRSP70 and ARC70), which is a
subunitofthehumanMediatorcomplex(18,19),andelonginA,
a subunit ofatranscription elongationfactor previouslyknown
asSIII(20,21).Intheworkdescribedherewesetouttoidentify
thefullrangeofproteinspossessingtheconservedTFIISmotif,
which we call the LW motif because of the invariant leucine
andtryptophanresiduesitcontains.Wewantedtodothispartly
because oftheimplicationsasharedmotifcouldhave forthein
vivo properties of TFIIS and also to begin testing the contribu-
tionthemotifmightmaketothecontrollingdifferentaspectsof
nuclear function. We found that in humans six distinctive pro-
teins contain the motif and all appear to be nuclear. We have
testedwhethertheLWmotiffunctionsasadedicatedsignalfor
nuclear localization for two of proteins that contain it. For one
suchproteinnucleartargetingwasindependentoftheLWmotif
and instead required a region containing classic nuclear local-
ization signals (NLS). However, analysis of mutations in the
LW motif of TFIIS demonstrated that here the region was
necessary fornuclear targeting.We reasoned thatthis disparity
could be due to the LW motif region being a multifunctional
protein–protein interaction domain, i.e. the motif normally
functions in nuclear processes but in the case of TFIIS it
also operates in the cytoplasm to couple the protein to a carrier
that has its own means of nuclear import. Therefore we also
examined regions of TFIIS in an in vitro protein–protein inter-
actionassayandhave foundthat theLWmotifisindeedpartof
a domain with protein-binding activity.
MATERIALS AND METHODS
Expression constructs
cDNAs encoding all or part of the human TFIIS.o isoform
(P23193) and hIWS1 (BAB55198) were cloned into the
following vectors. Vector pcDNA3.1/His/6myc was used to
create myc-tagged constructs. It was derived from pcDNA3.1/
HisC (Invitrogen) by cloning into the BamHI site a BglII/
BamHI PCR fragment from MT-6D (22) that encodes six
tandem copies of a 13 amino acid sequence containing the
myc epitope. In addition to full-length cDNAs, myc-tagged
deletion constructs of TFIIS and hIWS1 were created, all
by subcloning PCR-derived fragments into the EcoRI/NotI
or EcoRI/XhoI sites, respectively, of pcDNA3.1/His/6myc.
This vector was also used for the cloning of site-speciﬁc
TFIISmutants. These mutantswere madeby PCR asdescribed
previously (23) using Pfu Turbo DNA polymerase (Strata-
gene) and mutagenic primers that resulted in the substitution
of the residues in the LW motif indicated in Figure 5. Vector
pcDNA3.1/His/6myc/PK was made by cloning a BglII/BamHI
PCR fragment encoding residues 20–410 of pyruvate kinasae
(PK) derived from an existing plasmid (24) into the BamHI
site downstream of the myc-tag in pcDNA3.1/HisC/myc.
Plasmids encoding PK-tagged fusions were then created by
inserting the required cDNA fragments in-frame downstream
of PK in this vector. Vector pGEX-4T-1 was used to create
constructs for expression of GST-tagged TFIIS fusions in
Escherichia coli. These plasmids were constructed by subclo-
ning the respective deletion fragments from the pcDNA3.1/
His/6myc series into the EcoR I/NotI sites of pGEX-4T-1.
Details of the procedures and sequences of oligonucleotide
primers used in these constructions are available upon request.
DNA sequences of recombinant plasmids were conﬁrmed
using a Big Dye Terminator kit (ABI) and ABI automated
sequencer.
A construct that encoded rat PIBP (NP 001014282) cloned
in vector pFLAG-CMV5c was kindly provided by Dr Paul
Whitley (University of Bath, UK).
Tissue culture and transfection
HeLa cells were maintained in DMEM) (Gibco BRL) supple-
mented with 10% foetal calf serum and penicillin and strep-
tomycinat100 U/mland100mg/ml,respectively (GibcoBRL)
and were passaged at a ratio of 1:10. The day prior to trans-
fection cells were seeded at 2 · 10
5 cells per well in six-well
dishes that also contained a 22 mm
2 coverslip where required
for subsequent cytological analyses. Transfections were
carried out either using Effectene  transfection reagent
(Qiagen) or Lipofectamine plus  reagent (Gibco BRL)
according to the manufacturer’s recommendations and the
cells incubated for a further 24 h. Treatment of transfected
cells with leptomycin B (LMB) was accomplished by incu-
bating cells with 10 ng/ml LMB (Sigma–Aldrich) for 3 h prior
to ﬁxation.
Veriﬁcation of polypeptides produced from transfected
constructs was obtained by immunoblotting cell extracts
that were ﬁrst run on 12% SDS–polyacrylamide gels and
then electroblotted to nitrocellulose membranes. Blocked
membranes were incubated with primary antibody (mAb
9E10; Boehringer) and then with a horseradish peroxidase-
conjugated goat secondary antibody (Amersham Biosciences).
Blots were developed using an enhanced chemiluminescence
(ECL) detection kit (Amersham Bioscience).
Cytological preparations and fluorescence microscopy
For indirect immunoﬂuorescence HeLa cells grown on covers-
lips were ﬁrst rinsed in phosphate-buffered saline (PBS)
(137 mM NaCl, 2.7 mM KCl, 10.2 mM Na2HPO4 and 1.8
mM KH2PO4, pH7.4) and then ﬁxed by incubation in 4%
paraformaldehyde at room temperature for 10 min. They
were then permeabilized in 0.5% Triton X-100 for 10 min
at 4 C and incubated in 10% foetal bovine serum (FBS)
[First Link (UK) Ltd] in PBS for 30 min to 1 h at room
temperature to block non-speciﬁc binding of antibodies. Cov-
erslips were then incubated for 1 h at room temperature with
primary antibodies diluted in 10% FBS as follows: mAb 9E10
(Boehringer), to 1 mg/ml; mouse anti-FLAG, 1:400; serum
36H against human TFIIS, 1:500 [we generated 36H against
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after over-expression in E.coli and used to produce antiserum
as described previously (25)]. Coverslips were then washed
three times for 5 min each with 10% FBS, and then incubated
for 1 h at room temperature with the following secondary
antibodies (Molecular Probes) diluted to 1–2 mg/ml in PBS:
Alexa 488- or 546-conjugated goat anti-mouse IgG; Alexa
594-conjugated goat anti-rabbit IgG. Finally after three 5
min washes in PBS the coverslips were mounted in 50% glyc-
erol/PBS and sealed with clear nail varnish. Differential inter-
ference contrast (DIC), and ﬂuorescence observations were
made and recorded as described previously (25).
GST pull-down assays
GST-TFIIS fusion proteins were expressed in E.coli strain
JM105. Glutathione agarose (Sigma) was used for puriﬁcation
of the GST fusions according to the manufacturer’s instruc-
tions. The purity and concentration of protein samples were
estimatedbySDS–PAGE.Invitrotranscriptionandtranslation
of an hIWS1 derivative (residues 437–819) was carried out
with the TNT -coupled rabbit reticulocyte lysate system
(Promega) on a closed circular template according to the
manufacturer’s recommendations. The
35S-labelled protein
was analysed by electrophoresis through SDS–PAGE before
visualization and quantiﬁcation of bands representing intact
proteins by phosphorimaging. Pull-down assays for protein–
protein interactions between
35S-labelled hIWS1 and GST-
hTFIIS derivatives were carried out as described previously
(23,26).
RESULTS AND DISCUSSION
Identification of novel proteins containing the
highly conserved LW motif
It has been established by limited proteolysis, NMR spec-
troscopy and X-ray crystallography that TFIIS is a modular
proteinof three domains (14,17). The mostN-terminal of these
(domain I) comprises  130 amino acids and exhibits two
distinct sub-regions. The C-terminal 50 amino acids of TFIIS
domain I are not conserved and are unstructured. However
the 80 or so N-terminal residues exhibit high cross-species
sequence conservation and NMR data for yeast TFIIS shows
that this region forms a closely packed four-helix bundle, a
structure that has also been predicted for human TFIIS (17).
Furthermore, within the N-terminal region a sequence motif of
 50 residues that corresponds to helices 2, 3 and 4 has also
been identiﬁed in two other proteins, elongin A and MED 26
(17). In order to deﬁne this motif more fully and to determine
how widespread it might be, we carried out BLAST and Psi-
BLAST (27) searches using TFIIS, elongin A and MED 26
query sequences from a range of species. By using invariant
leucine and tryptophan residues as key criteria to assess
matches to the ‘LW motif’ (Figure 1A) we found that in
addition to MED26, elongin A isoforms, TFIIS isoforms
and products of likely pseudogenes, the human proteome
contains the following other examples:
(i) PPP1R10, a nuclear regulatory subunit of protein
phosphatase 1 (28) that was previously known as p99
or FB19 (29) or, in rat, as PNUTS (30). Although
automated computer annotation has also marked the
similarity with TFIIS domain 1 and led to suggestions
that PPP1R10 is involved in transcription (28), so far
there seems no direct evidence for this involvement
and there is some indication of a role in RNA proces-
sing (29).
(ii) PIBP, a small (208 amino acids), hypothetical protein
(FLJ32112) that has been predicted from full-length
human cDNA and whose rat orthologue was selected
as a phosphoinositide binding protein in a phage
display screen for binding to PtdIns(3,5)P2 [(31) and
Dr Paul Whitley, University of Bath, UK, personal
communication].
(iii) hIWS1, another hypothetical protein (FLJ14655) predic-
ted from human cDNA, whose C-terminal region has
extensive sequence similarity with the protein encoded
in yeast by the essential gene IWS1 (32,33). Within both
the human Iws1 protein (hIWS1) and yeast Iws1 the LW
motif is located relatively close to the C-terminus rather
than being almost N-terminal as in TFIIS and the other
LW motif-containing proteins (Figure 1B). Comparison
of the LW motifs of Iws1 and TFIIS in yeast and human
confirms the invariant and the highly conserved residues
that we have used to identify the motif unambiguosly
even among superficially weak database matches
(Figure 1B). Iws1 is known to associate with the elonga-
tion factor Spt6 (32) and there are genetic interactions
between IWS1 and genes encoding elongation factors
Spt4 and Spt5 (33) as well as an allele of TATA-binding
protein (34). It is therefore thought that Iws1 functions in
both transcription initiation and elongation (35).
Our analyses therefore identify Iws1 as the second yeast
protein in addition to TFIIS that possesses an LW motif
and, because this feature has been conserved in the human
Figure1.TheLWsequencemotif.(A)IdentificationoftheLWmotifindiverse
humanpolypeptides.TheextentoftheLWmotifisindicatedbyarrowsabovea
CLUSTALW 1.7 (47) alignment that was manually adjusted to position any
gapstotheinterhelicallinkerregionsofthestructurepredictedforthisregionof
human TFIIS (17). Identical or functionally similar residues are outlined in
blackandtheasterisksatthebottomindicatetheinvariantresiduesthatweused
to define the motif. Amino acid co-ordinates are given at the start of each
sequence.Conceptualtranslationproductswerepredictedfromsequenceswith
the following nucleotide database accession numbers: TFIIS isoforms,
M81601, D50495, AK027024; elongin A isoforms, L47345, AB030834,
AB076840; Med26, AF104253; PPP1R10p, Y13247; PIBP, AK056674;
hIWS1, AK027561. (B) Sequence conservation of LW motifs between yeast
and human in TFIIS and Iws1. Again,identical or functionallysimilar residues
are outlined in black and the asterisks indicate the invariant residues used to
define the motif.Above are indicatedthe positions of the four helices compris-
ing yeast TFIIS domain I as predicted by Booth et al. (17).
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function in both proteins. Since the previously identiﬁed LW
motif proteins are transcription factors, such proteins have
been assumed to be nuclear in their distribution, and in
some cases a predominantly nuclear localization has been
demonstrated (21,36). Of the LW motif proteins newly iden-
tiﬁed here, PPP1R10 has already been shown to be a nuclear
protein by immunolocalization (29,30). In order to determine
whether all LW motif containing proteins, and by implication
the LW motif itself, are likely to have predominantly nuclear
functions, we examined the cellular localization of the other
two new examples, PIBP and hIWS1.
Nuclear targeting and subnuclear localization of
LW motif containing proteins
HeLa cells were transfected with myc-tagged hIWS1 or
FLAG-tagged rat PIBP and the localization of the epitope-
tagged proteins determined by immunostaining in comparison
with that of myc-tagged and endogenous TFIIS. Both hIWS1
(Figure 2A) and PIBP (Figure 2A and B) were predominantly
nuclear in their distribution and were at least as efﬁciently
targeted to the nucleus as human TFIIS, both with respect to
the partitioning of staining between nucleus and cytoplasm
within a given cell and with respect to the percentage of
transformed cells exhibiting the typical pattern. hIWS1 had
a diffuse, somewhat punctate and non-nucleolar distribution
pattern (Figure 2A), essentially the same as that of TFIIS.
However, in addition to beinggenerally distributed throughout
the nucleus, PIBP was also present at high levels in the nucle-
oli of cells expressing low to moderate amounts of the tagged
protein (Figure 2B), and in cells with very high levels of
expression PIBP appeared to accumulate at the nucleolar
periphery. The distinctiveness of PIBP subnuclear localization
is emphasized by double immunostaining for endogenous
TFIIS (Figure 2B), in which PIBP localization is highest in
nucleoli where TFIIS concentration is at its lowest. Further
diversity in subnuclear distribution of LW motif proteins is
apparent in the localization described previously for PPP1R10
in HeLa cells (29), which is exempliﬁed by a punctate nucleo-
plasmic staining pattern that also includes several bright
nucleoplasmic bodies and similar discrete accumulations in
nucleoli. We did not observe the accumulation of hIWS1,
PIBP or TFIIS in such nucleoplasmic bodies, even though
we have shown previously that in amphibian oocytes TFIIS
is enriched in Cajal bodies (25).
OverallthereisnoevidencethattheLWmotiffunctionsasa
signal for ensuring the delivery of proteins to a particular sub-
nuclear compartment. However since we can now conclude
that LW motif proteins do at least share the property of nuclear
localization it seemed possible that the motif could function as
a signal for nuclear import. Clearly though if the LW motif
were a dedicated nuclear import signal it would be much
longer than the classic NLS ﬁrst characterized in the SV40
T-antigen [reviewed by (37)]. Instead it would be more analo-
gous to examples such as the 38 amino acid M9 domain,
which acts as the nuclear import signal for hnRNPA1
(38,39). A further complexity is that computer prediction
using the PSORTII algorithm (40) identiﬁes multiple potential
NLS patterns in all the LW motif proteins except TFIIS. To
determine whether the LW motif has a dedicated nuclear
targeting function we set out to identify experimentally the
sequences required for the targeting of hIWS1, which has one
of the weaker NLS scores among LW motif proteins, and of
the human TFIIS.o isoform, which has no predicted NLS.
Nuclear targeting of hIWS1 is dependent on NLS not
LW motifs
hIWS1 (Figure 3A) consists of 819 amino acids, of which an
N-terminal region of  500 residues is highly acidic while a
C-terminal region of  250 residues is well conserved in yeast
and includes the LW motif (amino acids 638–688). Two
potential NLS patterns occur in the central portion of the
polypeptide [KK(X)11KKQK at 358 and KRRR at 542] and
we ﬁrst tested whether a myc-tagged hIWS1 fragment
containing these signals but not the LW motif was capable
hIWS1
hTFIIS.o
PIBP
PIBP TFIIS
10 µm
A
B
Figure 2. Nucleartargeting and subnuclear localization of hIWS1 and PIBP in
HeLa cells. (A) The top panel shows a fluorescent image (and corresponding
DIC image) of cells expressing myc-tagged hIWS1 that have been immunos-
tained with mAb 9E10 against the tag. For comparison the central panels show
the similar, predominantly nuclear localization pattern exhibited by the myc-
tagged human TFIIS.o isoform. The bottom panels are from cells expressing
FLAG-tagged PIBP,whichagainshowa predominantlynucleardistributionof
the tagged protein. (B) Cells expressing FLAG-tagged PIBP were co-stained
for endogenous TFIIS. Apart from a general nuclear staining, the subnuclear
localization patterns of the two proteins appear distinctive, with PIBP being
prevalent in nucleoli (arrows in DIC image) whereas TFIIS is relatively under-
represented in these organelles.
2222 Nucleic Acids Research, 2006, Vol. 34, No. 8of nuclear targeting. Indeed an N-terminal fragment corre-
sponding to amino acids 1–573 was targeted to the nucleus
as efﬁciently as full-length hIWS1 (Figure 3A), suggesting the
LW motif is not required for nuclear targeting. Conversely,
two C-terminal fragments corresponding to amino acids
573–819 and 573–776, respectively, had a more general
cellular localization pattern with the smaller fragment even
appearing to be predominantly cytoplasmic (Figure 3A). Since
Figure 3. AregioncontainingNLSsequencesbutnottheLWmotifsufficesfornucleartargetingofhIWS1(A)Immunolocalizationpatternsofmyc-taggedhIWS1
region1–573(which doesnot containthe LW motif) compared with regions573–819and 573–776(whichdo contain the LWmotif).Full-lengthhIWS1(1–819)is
shown as a control. The diagram below indicates the extent of the tagged polypeptides (numbered according to amino acid residues) and the basic organization of
hIWS1. The locations of the three potential NLS signals predicted in the hIWS1 sequence are indicated by downward arrows and the location of the LW motifi s
shownbyhorizontalarrows.TheregioncontainingthehighlyconservedsequencepresentinbothyeastandhumanandthatincludestheLWmotifisshaded,andtwo
otherwell-conservedregionsthatflankanextensiveregionpossessingmanyacidicresiduesareindicatedbyhatching.(B)Immunolocalizationofmyc-taggedfusions
betweenregionsofhIWS1andthelargecytoplasmicenzymepyruvatekinase(PK).Immunolocalizationofafull-lengthhIWS1–PKfusionandofPKaloneareshown
as controls. Above the fluorescent images the hIWS1 fragments used in the fusions are drawn with respect to the overall organization of the polypeptide.
Nucleic Acids Research, 2006, Vol. 34, No. 8 2223these C-terminal constructs contain the LW motif, as well as a
third potential NLS (amino acid 713), it would appear that the
LW motif does not accomplish efﬁcient nuclear targeting. In
order to test if the central NLS region was necessary and
sufﬁcient for targeting, we constructed myc-tagged fusions
of parts of hIWS1 with the large enzyme pyruvate kinase
(PK), which is normally conﬁned to the cytoplasm. As before
the C-terminal 573–819 fragment of hIWS1 containing the
LW motif did not cause efﬁcient nuclear targeting, and in
fact this large PK fusion was conﬁned to the cytoplasm to
the same extent as PK alone (Figure 3B). However the
N-terminal hIWS1 1–579 fragment was able to target the
PK fusion to the nucleus as efﬁciently as did full-length
hIWS1 (Figure 3B). Moreover, a PK fusion with a subfrag-
ment of hIWS1 comprising residues 325–579, which includes
both the potential NLS patterns of the central region, showed
efﬁcient nuclear targeting. Therefore it appears that NLS
rather than LW motifs are necessary and sufﬁcient to ensure
efﬁcient nuclear targeting of hIWS1.
The LW motif of human TFIIS is necessary for
nuclear targeting
Although the previous results showed that the LW motif is not
a specialized nuclear targeting domain, we wanted to test
whether in some circumstances it could sufﬁce for this pur-
pose, namely in proteins such as human TFIIS.o that appear to
lack conventional nuclear targeting signals. As an initial
approach we divided hTFIIS.o into three segments, residues
1–77, which include the LW motif, 78–171 and 172–301,
based upon the broad patterns of sequence conservation
exhibited by vertebrate TFIIS isoforms (Figure 4). A set of
ﬁvemyc-taggedconstructseachcontainingadifferentsegment
or combination of segments of hTFIIS.o were expressed in
HeLa cells, and the cells immunostained to assess targeting
efﬁciency relative to full-length hTFIIS (Figure 4). As before,
most cells transfected with full-length hTFIIS.o exhibited pre-
dominantly nuclear localization, with the remainder showing
about equal staining of nucleus and cytoplasm. The two con-
structs that contained the LW motif, 1–77 and 1–171 showed a
similar degree of nuclear localization to that of full-length
TFIIS. However, with the remaining constructs, which lacked
segment 1–77, the distribution of the tagged protein was no
longer predominantly nuclear and the cells showed a level of
cytoplasmic staining that either was similar to or stronger than
that of the nucleus. We have conﬁrmed the ﬁnding that only
myc fusion proteins containing segment LW motif exhibit a
predominantly nuclear distribution in analogous constructs
derived from Xenopus TFIIS.o in HeLa cells (data not
shown). Therefore it does appear that the LW motif within
segment 1–77 could contain the signals responsible for the
nuclear targeting of TFIIS.
In order to test further this potential targeting role for the
LWmotif,weﬁrstconstructedfusionproteinsbetweenPKand
all or part of hTFIIS. However nuclear targeting of even full-
length TFIIS was disrupted in the fusion proteins, which
remained conﬁned to the cytoplasm (data not shown). This
effect was seen when PK was fused to either the N-terminus or
to the C-terminus of TFIIS and could be due to a dominant
inﬂuence of PK on structure/function of the LW motif.
Alternatively it might point to a diffusion-based mode for
TFIIS nuclear entry that cannot operate simply because of
the large size of these fusion proteins. In another attempt to
examine the potential role of the LW motif in targeting we
created ﬁner-scale mutations in the region. In the ﬁrst of these,
hND30, the ﬁrst 30 amino acids of hTFIIS.o were deleted
(Figure 5). This deletion removes most of the ﬁrst helix of
the three into which the LW motif region is folded, and may
also disrupt the rest of the structural domain. We found that
hND30 was not targeted to the nucleus; instead in 80% of
transfected cells it exhibited strong cytoplasmic localization
and in the remainder was generally distributed throughout the
cell (Figure 5). This distribution pattern suggests that an
almost total disabling of the nuclear targeting function of
the N-terminal region by the hND30 deletion.
Wethen usedaset ofpoint mutationstodetermine the effect
of substituting amino acids in the hTFIIS.o LW motif that are
Figure 4. HumanTFIISpolypeptidesthatcontainthe LWmotifshowefficient
nuclear targeting. The diagram indicates the general organisation of TFIIS and
the regions of the hTFIIS.o isoform used in our myc-tagged constructs. The
C-terminal region 172–301 is highly conserved, and in terms of the structure/
function properties of TFIIS [reviewed in (11)] includes the intact Zn ribbon
domain,andaportionofdomainII.Region1–77containsthehighlyconserved
LWmotifandrepresentsthatpartofdomainIwithadefinedstructure.Residues
78–301 can confer all known transcriptional functions of TFIIS. The central
panel shows immunofluorescent images of cells expressing the corresponding
myc-tagged constructs stained with mAb 9E10. The lower panel shows
immunoblotsofdeletionproductsandfull-lengthTFIISfromtransfectedHeLa
cell extracts probed with mAb 9E10. un ¼ control extract from untransfected
cells.
2224 Nucleic Acids Research, 2006, Vol. 34, No. 8conserved to different extents and/or that are proposed to play
distinctive structural roles in the domain (Figure 5). These
hTFIIS mutants were expressed as full-length (Figure 6A)
myc fusionsin HeLa cellsand exhibited a range ofphenotypes.
In particular substitution of four LW motif residues (L28, L31,
T44 and W73) had severe effects on cellular distribution of the
fusion proteins and caused the complete absence of nuclear
localized hTFIIS (Figure 5). In particular, the L28R and L31R
Figure 5. Effect of LW motif mutations on the nuclear targeting efficiency of TFIIS. The sequence of hTFIIS.o is shown with conserved and invariant residues
indicated as in Figure 1A and with the locations of nine substitution mutations (black dots) and a deletion mutation (hND30; broken line) also shown. Below are
representativesamplesofimmunostainedcellsexpressingthemutantformsofmyc-taggedTFIIS.Therelativestrengthofnucleartargetingbyeachmutantisgivenin
thetableatthebottomtogetherwiththestructuralrolepredictedforthesubstitutedresiduebyBoothetal.(17).Targetingefficiencywasassessedonthebasisofthe
most common localization pattern observed for each mutant as well as the proportion of cells still exhibiting the predominantly nuclear distribution observed for
wild-type TFIIS, and is expressed on a scale from no nuclear targeting ( ) to wild-type levels (+++).
Nucleic Acids Research, 2006, Vol. 34, No. 8 2225mutations resulted in cytoplasmic accumulation of hTFIIS
in the majority of cells, demonstrating that unlike hIWS1,
nuclear targeting of this protein requires the LW motif. How-
ever, as discussed below, this targeting role in the context of
TFIIS may be best explained as a secondary consequence of a
more general function for the LW motif. These results also
suggest that the nuclear targeting mechanism that is disrupted
is one of active nuclear import rather than one of passive
diffusion followed by active nuclear retention, which can
be exhibited by some small proteins. We favour this inter-
pretation because the clear cytoplasmic accumulation of TFIIS
(rather than its free cellular diffusion) as a result of the L28R
and L31R point mutations and the hND30 deletion seems
difﬁcult to reconcile with a diffusion-based transport mecha-
nism. However, it is conceivable that these cytoplasmically
localized mutants are actively excluded from the nucleus as
the result oftheir becoming substrates,unlike wild-typeTFIIS,
for nuclear export. To address this possibility we examined the
effect of incubating cells transformed with mis-localizing
TFIIS mutants in leptomycin B (LMB), which inhibits
CRM1-dependent nuclear export (41). We found that LMB
treatment did not lead to the nuclear accumulation of mutants
L28R (Figure 6B) or L31R (data not shown), indeed there
appeared an even more frequent occurrence of cytoplasmic
localization than in untreated cells examined in parallel.
Finally, a role for the LW motif primarily in nuclear retention
is not supported by the behaviour of the IWSL 573–776
construct, which contains the LW motif and comprises only
 200 amino acids but which is cytoplasmically localized
rather than accumulating in the nucleus (Figure 3A).
Figure 6. ExpressionofTFIISmutantL28RinHeLacells.(A)Immunoblotofmyc-taggedTFIISwildtype(wt)andpointmutants(1–6)fromextractsoftransfected
HeLacellsprobedwithmAb9E10.Mutantsshownarelane1,T37K;lane2,L31R;lane3,L28R;lane4,L25K;lane5,A9P;lane6,A9D.(B)Theeffectofleptomycin
B (LMB) on the cytoplasmic localization of hTFIIIS mutant L28R. HeLa cells expressing L28R were incubated in the presence (+) or absence ( ) of LMB prior to
immunostaining TFIIS with serum 36H. The distributions of overexpressed TFIIS mutant or wild-type polypeptides are shown in comparison with nuclear DAPI
staining. (In comparison with 9E10, 36H does not contribute to detectable cytoplasmic immunostaining, rather endogenous TFIIS produces only faint background
nuclear staining at the imaging exposures used here).
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The effects of substituting particular amino acids in the LW
motif ranged from the complete abolition of nuclear targeting
and the generation of either a cytoplasmic or general cellular
distribution of TFIIS, to slight effects in which nuclear locali-
zation was preserved in many or even the majority of cells
(summarized in Figure 5). The level of the effect on nuclear
targeting appears to show some correlation with the degree of
evolutionary conservation of the substituted residues. For
example, mutations L31R and W73K, which change the
invariant residues deﬁning the LW motif, markedly reduced
nuclear targeting . However in some cases substituting highly
conserved or even invariant residues such as L41K caused
much less disruption of targeting. There is a better correlation
betweentheeffectofamutationontargetingandthelocationof
the substituted residue in the structure proposed for domain I
of human TFIIS. Booth et al. (17) predicted the residues form-
ing the hydrophobic core of the domain and identiﬁed con-
served surface residues that presumably could contribute to
interactions with other proteins. As summarized in Figure 5,
the more severe examples of disrupted nuclear targeting were
observed when hydrophobic core residues were mutated
whereas substitution of surface residues was associated with
milder, if any, effects on targeting. This correlation can be
interpreted as simply reﬂecting the greater potential of any
single substitution when in the hydrophobic core to disrupt
the overall structure/function properties of the domain. Nev-
ertheless it is noteworthy that the effect on nuclear targeting
provides a ﬁrst in vivo functional assay for domain I of TFIIS
andthatassuchitsupportsthemodelforhumanTFIISdomainI
that was modelled on the solution structure determined for
yeast TFIIS by Booth et al. (17).
Protein–protein interaction: a function for the
LW motif in diverse nuclear proteins?
Overall, our experiments with hIWS1 suggest that, despite its
conservation in six distinctive nuclear proteins, the LW motif
is unlikely to function in vertebrate cells as part of a dedicated
nuclear targeting mechanism. However, human TFIIS appar-
ently represents an exception, because in the absence of an
NLS-based mechanism of nuclear localization it appears to
have developed a reliance on the LW motif for nuclear target-
ing. This should be contrasted with the situation in yeast where
it iswell established thatthe N-terminal regionof TFIIScan be
removed without damaging its nuclear functions (11) and that
the presence of the LW motif is not required for nuclear locali-
zation of TFIIS (Rachel Fish and Caroline Kane, personal
communication). Interestingly, in yeast the import receptor
Nmd5p/Kap119p has been shown to be the main effector of
TFIIS nuclear import (42). This protein is one of many mem-
bers of the importin-b superfamily that provide an alternative
to NLS-based nuclear import, although since presumably it
acts via a part of yeast TFIIS other than the N-terminal region,
we would predict that a role in TFIIS import would not be
conserved in any mammalian orthologues. However, it is
clearly a possibility that the apparent acquisition by the
TFIIS LW motif of a nuclear targeting function in human
cells is due to an ability to interact directly with another of
the range of dedicated import receptors. However, there is
another possible explanation. Many nuclear proteins, includ-
ing components of the MCM complex of replication proteins
(43) and the basal transcription/DNA repair factor TFIIH (44),
themselves lack a dedicated import signal and instead utilize a
mechanism of nuclear import that relies on a piggyback prin-
ciple; i.e. in the cytoplasm these proteins bind to a functionally
related partner protein(s) that does possess a nuclear import
signal such as an NLS and that acts as a carrier for nuclear
accumulation of both proteins.
Such an explanation for the nuclear targeting of human
TFIIS obviously requires that the region containing the LW
motif at least comprises a protein–protein interaction domain.
This possibility is supported by the ﬁnding that the N-terminal
region of TFIIS displays an efﬁcient interaction with a human
polIIholoenzymeduringproteinafﬁnitychromatography(15).
In order to examine more directly its potential for protein–
protein interactions, we have exploited the fact that in a
yeast two-hybrid screen with human TFIIS as the bait one of
the proteins we identiﬁed was hIWS1 (Y.Ling and G. Morgan,
manuscript in preparation). Therefore we were able to use a
GST pull-down assay with hIWS1 to test different parts of
TFIIS for the possession of a protein interaction domain. As
shown in Figure 7, GST–TFIIS fusions that contain the LW
motif either alone (TFIIS 1–77) or as part of a larger polypep-
tide (TFIIS 1–301 and 1–171) were able to bind efﬁciently to
hIWS1, whereas the C-terminal half of TFIIS (172–301) was
not. We conclude from this data that the human TFIIS LW
motifindeedfunctionsasaninvitroproteininteractiondomain,
although we do not know if these proteins ever interact in the
cytoplasm. Recently several other proteins binding the
N-terminal regions of TFIIS have been identiﬁed; the novel
human proteins FESTA and EloA-BP1, (36,45) and, in yeast,
components of the SAGA complex and of the mediator com-
plexes (46). It will be important to determine which, if any, of
Figure 7. The region of TFIIS containing the LW motif mediates a protein–
protein interaction. Pull-down assay of
35S-labelled hIWS1 binding to immo-
bilized GST-fusion proteins containing regions of TFIIS (indicated above the
lanes).Graphicalrepresentationofthisdataisshownbelowincomparisonwith
20% of the labelled input protein and a pull-down using GST alone.
Nucleic Acids Research, 2006, Vol. 34, No. 8 2227these TFIIS-binding proteins might serve as the in vivo car-
rier(s) for human TFIIS via the cytoplasmic binding of its LW
motif.
In a broader context, the evidence that the LW motif
in TFIIS is a protein–protein interaction domain invites the
question of whether among the diverse nuclear proteins
containing it the motif has a common role. For instance, if
all LW motif proteins were involved in different aspects of the
same process, namely transcriptional control, they might all
interact with common nuclear target protein(s) or other mole-
cule via their LW motif regions. However, the diversity among
these proteins with respect to subnuclear localization and their
predicted functions or properties could also mean that each
individual LW motif is an interaction module utilized for
binding different partners involved in distinctive nuclear
processes. One useful approach will be to test the extended
complement of LW motif containing proteins we have
described for their ability to interact with the various TFIIS
N-terminal domain binding proteins.
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